ClinicalTrials.govpublic full text
TIL and Anti-PD1 in Metastatic Melanoma
toxicity, drug, adverse drug event, effects of immunotherapy, metastatic melanoma, anti-pd1, til, interferon-alpha, adoptive cell therapy, nivolumab, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1009054
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.